Vega Investment Solutions acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,352 shares of the conglomerate's stock, valued at approximately $2,353,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DHR. Meeder Asset Management Inc. bought a new position in Danaher in the second quarter worth approximately $44,000. MidFirst Bank bought a new stake in shares of Danaher during the second quarter valued at approximately $46,000. Bell Investment Advisors Inc bought a new stake in shares of Danaher during the second quarter valued at approximately $47,000. Solstein Capital LLC acquired a new position in shares of Danaher during the second quarter worth approximately $58,000. Finally, State of Wyoming bought a new position in shares of Danaher in the 2nd quarter worth $74,000. 79.05% of the stock is owned by institutional investors.
Danaher Price Performance
DHR opened at $215.18 on Tuesday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a market capitalization of $151.27 billion, a price-to-earnings ratio of 38.22, a P/E/G ratio of 2.72 and a beta of 0.78. The firm's fifty day moving average price is $196.49 and its two-hundred day moving average price is $192.39.
Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the prior year, the company posted $0.77 earnings per share. The firm's revenue for the quarter was up 5.5% on a year-over-year basis. As a group, analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several analysts recently issued reports on the stock. Weiss Ratings raised shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, July 15th. Guggenheim dropped their price objective on shares of Danaher from $235.00 to $200.00 and set a "buy" rating on the stock in a research note on Wednesday, July 22nd. Wells Fargo & Company decreased their target price on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 22nd. Stifel Nicolaus dropped their price target on shares of Danaher from $260.00 to $220.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. Finally, DZ Bank started coverage on Danaher in a research note on Wednesday, June 3rd. They set a "buy" rating and a $210.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $228.91.
Check Out Our Latest Stock Analysis on Danaher
About Danaher
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
